
Opinion|Videos|August 16, 2024
Clinical Insights With Subcutaneous Biologics
Author(s)Jennifer Seminerio, MD
An expert gastroenterologist highlights what her experience has been like with subcutaneous biologics.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How long have you been using subcutaneous biologics in your practice, for which indications, and what has your overall experience been like?
Advertisement
Related to this article

New unattended sleep testing codes take effect Jan. 1, 2027 — but a dispute over how CMS values them could shape access to the cheaper alternative to in-lab sleep studies.

A session at AAO 2026 explained how Medicare, Medicare Advantage and commercial coverage policies differ in ophthalmology, and how practices can document and code to stay compliant

Presenters at AAO 2026 examined hospital eye coverage gaps, workforce strain and how ophthalmology can gain influence within health systems.

Price transparency data on 11 glaucoma surgery codes showed payer class was most consistently tied to price, with Medicaid and self-pay rates lowest.

Experts at Fall Clinical Derm 2026 urge early JAK inhibitors over systemic steroids for atopic dermatitis and long-term vitiligo treatment, saying boxed-warning risks are overstated.

Art Papier, M.D., CEO of VisualDx, says darker skin tones have been underrepresented in dermatology resources for decades and explains how his company works backward from known diagnostic errors.

The 2026 American Academy of Ophthalmology Meeting got started today in New Orleans with a mix of celebration and candor about the challenges facing ophthalmology today.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Ophthalmology coverage hinges on knowing the payer | AAO 2026
2
Experts urge earlier JAK inhibitor use in AD and vitiligo | Fall Clinical Derm 2026
3
A conversation about the cycle of ADHD and sleep problems in children, with Alison Pritchard, Ph.D.
4
2026 PBMI Annual National Conference
5




